Ovid Therapeutics Inc (NASDAQ:OVID) Insider Trading Activity – Major Shareholder Bought 2,000,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Ovid Therapeutics Inc (NASDAQ:OVID)

Pharmaceutical Co Ltd Takeda , Major Shareholder of Ovid Therapeutics Inc (NASDAQ:OVID) reportedly Bought 2,000,000 shares of the company’s stock at an average price of 2.5 for a total transaction amount of $5,000,000.00 SEC Form

Insider Trading History For Ovid Therapeutics Inc (NASDAQ:OVID)

  • On 8/25/2017 Jeremy M Levin, CEO, bought 15,334 with an average share price of $7.15 per share and the total transaction amounting to $109,638.10.
  • On 8/14/2018 Douglas E Williams, Director, bought 5,000 with an average share price of $6.49 per share and the total transaction amounting to $32,450.00.
  • On 2/22/2019 Jeremy M Levin, CEO, bought 75,000 with an average share price of $2.00 per share and the total transaction amounting to $150,000.00.
  • On 2/26/2019 Karen Bernstein, Director, bought 10,000 with an average share price of $2.02 per share and the total transaction amounting to $20,200.00.
  • On 10/8/2019 Pharmaceutical Co Ltd Takeda, Major Shareholder, bought 2,000,000 with an average share price of $2.50 per share and the total transaction amounting to $5,000,000.00.
  • On 10/8/2019 Jeremy M Levin, CEO, bought 60,000 with an average share price of $2.13 per share and the total transaction amounting to $127,800.00.

    • Analyst Ratings History For Ovid Therapeutics Inc (NASDAQ:OVID)

    • On 12/17/2018 Cantor Fitzgerald Set Price Target of rating Buy with a price target of $10.00
    • On 3/8/2019 JMP Securities Lower Price Target of rating Outperform with a price target of $26.00 to $11.00
    • On 5/16/2019 LADENBURG THALM/SH SH Reiterated Rating Buy with a price target of $27.00
    • On 9/4/2019 Royal Bank of Canada Initiated Coverage of rating Outperform with a price target of $12.00
    • On 9/23/2019 Piper Jaffray Companies Set Price Target of rating Buy with a price target of $14.00
    • On 9/24/2019 Citigroup Boost Price Target of rating Buy with a price target of $8.00 to $10.00
    • On 11/11/2019 Cowen Reiterated Rating Buy

    Recent Trading Activity for Ovid Therapeutics Inc (NASDAQ:OVID)
    Shares of Ovid Therapeutics Inc closed the previous trading session at 2.68 0.00 0.00% with 241600 shares trading hands.